Variant report
Variant | nsv947277 |
---|---|
Chromosome Location | chr1:80502617-80510960 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560677230 | chr1:80502629-80502630 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs549829219 | chr1:80502672-80502673 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs150741978 | chr1:80502743-80502744 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs181350547 | chr1:80502757-80502758 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs547421264 | chr1:80502800-80502801 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs374785954 | chr1:80502865-80502866 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563943683 | chr1:80502879-80502880 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs139117267 | chr1:80502953-80502954 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs557985680 | chr1:80503057-80503058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576273997 | chr1:80503059-80503060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186359976 | chr1:80503117-80503118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs145134058 | chr1:80503127-80503128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs147708870 | chr1:80503155-80503156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs190019733 | chr1:80503163-80503164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540786267 | chr1:80503203-80503204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181448521 | chr1:80503206-80503207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572702808 | chr1:80503222-80503223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs532831517 | chr1:80503223-80503224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs546152711 | chr1:80503296-80503297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs186086551 | chr1:80503299-80503300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs116242532 | chr1:80503310-80503311 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs140936826 | chr1:80503319-80503320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs369545382 | chr1:80503338-80503339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555358962 | chr1:80503410-80503411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs374691074 | chr1:80503411-80503412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs144896448 | chr1:80503417-80503418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs561842102 | chr1:80503421-80503422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs529309281 | chr1:80503476-80503477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs2184613 | chr1:80503523-80503524 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs565886454 | chr1:80503557-80503558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs145881084 | chr1:80503558-80503559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs569897269 | chr1:80503559-80503560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs111922815 | chr1:80503597-80503598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs555544613 | chr1:80503631-80503632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs567366725 | chr1:80503632-80503633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs566133414 | chr1:80503645-80503646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs148925225 | chr1:80503739-80503740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs191197039 | chr1:80503780-80503781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs533936227 | chr1:80503796-80503797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs201453507 | chr1:80503839-80503840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs143678597 | chr1:80503875-80503876 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs546122932 | chr1:80503886-80503887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs544303036 | chr1:80503951-80503952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs372207208 | chr1:80503952-80503953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs183318421 | chr1:80504020-80504021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs576274805 | chr1:80504059-80504060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs111395390 | chr1:80504063-80504064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12048600 | chr1:80504154-80504155 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs535315882 | chr1:80504185-80504186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs529390665 | chr1:80504247-80504248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Type 2 diabetes | 21956041 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Cancer | 22429812 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:80502400-80502800 | Active TSS | Foreskin Fibroblast Primary Cells skin01 | Skin |
2 | chr1:80502400-80503000 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr1:80502600-80503000 | Active TSS | IMR90 fetal lung fibroblasts Cell Line | lung |
4 | chr1:80502600-80503000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr1:80503000-80503400 | Enhancers | Fetal Heart | heart |
6 | chr1:80503200-80504000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr1:80504000-80507600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr1:80507600-80508200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr1:80508200-80508600 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr1:80508600-80508800 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |